Clinical Trials in Chicago

Showing 7821-7840 of 20,493 trials

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

NCT03934840

This is a phase II clinical trial in patients with metastatic castration sensitive prostate cancer. The objective of the study is to determine the efficacy and further define the safety of the treatment combination. This study will evaluate dose levels of carboplatin AUC 4 with cabazitaxel 20 mg/m2. Patients will be treated with the combination of ADT and carboplatin and cabazitaxel for 6 cycles. After 6 cycles of chemotherapy, they will start abiraterone with ADT. The primary objective is to determine the percent of subjects that have no PSA or radiographic progression at 1 year. Secondary objectives will include determining the progression-free survival, time to PSA nadir and time to PSA progression of carboplatin and cabazitaxel in combination with ADT.

Prostate Cancer

Masonic Cancer Center, University of Minnesota22 participantsStarted Oct 2019

Phoenix, Arizona, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +5 more locations

COMPLETED2.2 miles

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

NCT01474811

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Hepatitis C

University of North Carolina, Chapel Hill13,559 participantsStarted Nov 2011

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +57 more locations

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Find Trials by Condition in Chicago

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

COVID-19 Convalescent Plasma

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)

A Study Investigating the Effects of a Novel Mindfulness Approach on Frequency and Duration of Meditation and Self-Reported Stress and Mood in Generally Healthy Adults

OCS Lung System EXPAND II Trial

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

Cardionomic STOP-ADHF Study

Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study

Pilot Prospective Study: Long-term Health of Living Kidney Donors

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)